WT
RYTM icon

Whittier Trust’s Rhythm Pharmaceuticals RYTM Stock Holding History

Whittier Trust’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$197K Sell
1,760
-51
-3% -$4.61K ﹤0.01% 626
2026
Q1 		$157K Hold
1,811
– – ﹤0.01% 634
2025
Q4 		$180K Hold
1,811
– – ﹤0.01% 617
2025
Q3 		$179K Buy
1,811
+51
+3% +$4.74K ﹤0.01% 607
2025
Q2 		$111K Hold
1,760
– – ﹤0.01% 770
2025
Q1 		$93.2K Hold
1,760
– – ﹤0.01% 799
2024
Q4 		$98.5K Sell
1,760
-240
-12% -$13.3K ﹤0.01% 794
2024
Q3 		$105K Hold
2,000
– – ﹤0.01% 783
2024
Q2 		$82.1K Hold
2,000
– – ﹤0.01% 812
2024
Q1 		$86.6K Hold
2,000
– – ﹤0.01% 815
2023
Q4 		$91.9K Buy
+2,000
New +$63.1K ﹤0.01% 786

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Whittier Trust's RYTM Position: Q2 2026 in Review

Whittier Trust reduced its Rhythm Pharmaceuticals (RYTM) stake by 2.8% in Q2 2026, selling an estimated $4.61K and leaving 1,760 shares worth $197K. The position accounts for ﹤0.01% of the portfolio, ranked #626.

Whittier Trust first reported a position in RYTM in Q4 2023 and has held it in 11 quarters since. 304 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • Whittier Trust held 1,760 shares of Rhythm Pharmaceuticals worth $197K as of Q2 2026.
  • Whittier Trust sold 51 Rhythm Pharmaceuticals shares in Q2 2026, an estimated $4.61K.
  • Rhythm Pharmaceuticals made up ﹤0.01% of Whittier Trust's portfolio in Q2 2026, its #626 holding.
  • Whittier Trust first reported a position in Rhythm Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
  • 304 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on Whittier Trust's 13F filing for Q2 2026, filed 28 Jul 2026.